Select Publications
Conference Papers
2008, 'The potential impact of a vaccine on chlamydia epidemiology and morbidity', in Sexual Health, CSIRO Publishing, Australia, pp. 1 - 1, presented at Sexual Health, Perth, 17 September 2008 - 20 September 2008
,2008, 'Predicting the effectiveness and key characteristics of Chlamydia vaccines using a sexual network and transmission model', in Proceedings of the Sixth Meeting of the European Society for Chlamydia Research, European Society for Chlamydia Research, Aarhus, Denmark, presented at 6th Meeting of the European Society for Chlamydia Research, Aarhus, Denmark, -
,Conference Posters
2018, 'Australia on track to achieve WHO elimination targets following rapid initial DAA treatment uptake', presented at International Liver Congress (European Association for the Study of the Liver (EASL 2018)), 11 April 2018 - 15 April 2018
,Conference Presentations
2020, 'DECREASING COMMUNITY VIREMIA IS ASSOCIATED WITH DECREASING HIV INCIDENCE IN AUSTRALIA', presented at Conference on Retroviruses and Opportunistic Infections, Boston, 08 March 2020, https://www.croiconference.org/abstract/decreasing-community-viremia-is-associated-with-decreasing-hiv-incidence-in-australia/
,2018, 'Ongoing Burden of Advanced Liver Disease Complications Despite Rapid HCV Treatment Scale-Up', presented at Australasian Viral Hepatitis Conference, 13 August 2018 - 15 August 2018
,2017, 'Australia Could Meet the WHO HCV Elimination Targets If the Current Rollout of DAA Treatment Is Continued', presented at Australasian Viral Hepatitis Conference (AVHC), 10 August 2017 - 11 August 2017
,Conference Abstracts
2024, 'Cost-effectiveness of interventions to prevent vertical transmission of HIV in Papua New Guinea', in Cost-effectiveness of interventions to prevent vertical transmission of HIV in Papua New Guinea, Sydney, presented at 45th Australian Health Economics Society (AHES) Conference, Sydney, 19 September 2024 - 20 September 2024
,2024, 'Costs and budget impact of scaling up clinic-based HIV viral load and infant diagnostic testing in Papua New Guinea', in Costs and budget impact of scaling up clinic-based HIV viral load and infant diagnostic testing in Papua New Guinea, Sydney, presented at 45th Australian Health Economics Society (AHES) Conference, Sydney, 19 September 2024 - 20 September 2024
,2024, 'Costs of establishing clinic-based viral load and infant diagnostic testing and HIV drug resistance monitoring in Papua New Guinea', in Costs of establishing clinic-based viral load and infant diagnostic testing and HIV drug resistance monitoring in Papua New Guinea, Sydney, presented at Australasian HIV&AIDS Conference, Sydney, 19 September 2024 - 20 September 2024
,2021, 'LIFETIME COST OF HIV MANAGEMENT IN AUSTRALIA: A MODELLING STUDY', in SEXUAL HEALTH, CSIRO PUBLISHING, Vol. 18, pp. VIII - VIII, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693686000018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Evidence of declining HCV transmission in Australia following scale-up of direct acting antiviral therapy', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 73, pp. S606 - S606, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587002012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men in New South Wales, Australia 2010 to 2018', in Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men in New South Wales, Australia 2010 to 2018, presented at World AIDS Conference 2020, http://dx.doi.org/10.26190/unsworks/27949
,2020, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men in New South Wales, Australia 2010 to 2018', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 23, pp. 36 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000551988900063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Will hepatitis C transmission be eliminated by 2025 among HIV-positive men who have sex with men in Australia?', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 21, pp. 66 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440002700139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'O12 Australia could meet the WHO HCV elimination targets if the current rollout of DAA treatment is continued', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 5 - 5, http://dx.doi.org/10.1016/s2055-6640(20)30895-5
,Reports
2024, Tracking the Progress 2023: Executive Summaries, Sydney, Australia, http://dx.doi.org/10.26190/unsworks/30154, https://www.kirby.unsw.edu.au/research/reports/tracking-progress-2023-executive-summaries
,2023, HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2023, Kirby Institute, UNSW Sydney, Sydney, UNSW, http://dx.doi.org/10.26190/f5ph-f972
,2023, HIV, viral hepatitis and sexually transmissible infections among people from culturally and linguistically diverse backgrounds in Australia: Enhanced surveillance report, The Kirby Institute, http://dx.doi.org/10.26190/4v8n-0m98
,2022, HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2022, The Kirby Institute, UNSW Sydney, Sydney, Australia, http://dx.doi.org/10.26190/sx44-5366, https://kirby.unsw.edu.au/report/asr2022
,2022, HIV, viral hepatitis and sexually transmissible infections in Australia Annual surveillance report 2021, The Kirby Insitute, UNSW Sydney, Sydney, Australia, http://dx.doi.org/10.26190/r0fj-4953, https://kirby.unsw.edu.au/report/asr2021
,2019, Hepatitis C Elimination in NSW: Monitoring Evaluation Report 2019, https://kirby.unsw.edu.au/report/hepatitis-c-elimination-nsw-monitoring-and-evaluation-report-2019
,2019, Modelling of the infectious syphilis outbreak in Indigenous Australians: guidance for Multi-Jurisdictional Syphilis Outbreak Working Group
,2018, Applying Decision Science to Inform HIV Resource Allocation in Belarus: Case study on how mathematical modelling techniques were used to change HIV budgets, The World Bank
,2018, HIV in Australia Annual surveillance short report 2018, Sydney: Kirby Institute, UNSW Sydney, http://dx.doi.org/10.26190/unsworks/28199
,2018, HIV, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2018, Sydney: Kirby Institute, UNSW Sydney, http://dx.doi.org/10.26190/nvtv-8t93
,2017, 2017 Estimates and Projections of the Hepatitis C Virus Epidemic in NSW: Summary Report, Sydney: Kirby Institute, UNSW Sydney
,2017, HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2017, Sydney: Kirby Institute, UNSW Sydney
,2017, HIV, viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2017, Sydney: Kirby Institute, UNSW Sydney
,2016, 2016 Annual Surveillance Report of HIV, viral hepatitis, STIs, The Kirby Institute, UNSW Australia, Sydney, Australia, http://kirby.unsw.edu.au/sites/default/files/hiv/resources/SERP_2016-Annual-Surveillance-Report_UPD170116.pdf
,2016, Optimizing investments in Belarus for the National HIV Response, The World Bank, Washington DC: World Bank., https://openknowledge.worldbank.org/handle/10986/25395
,2015, HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2015, http://kirby.unsw.edu.au/sites/default/files/hiv/resources/ASR2015_v5.pdf
,2015, Investing for results: How Asia Pacific countries can invest for ending AIDS., http://optimamodel.com/pubs/Investing_for_Results_2015.pdf
,2015, Optimizing Investments in Moldova’s HIV Response, https://openknowledge.worldbank.org/handle/10986/25396
,2015, Zambia’s HIV Response: Prioritized and strategic allocation of HIV resources for impact and sustainability. Findings from the HIV allocative efficiency study., World Bank, Washington, DC, http://hdl.handle.net/10986/22080
,2014, Sudan’s HIV response: Value for money in a low-level HIV epidemic - Findings from the HIV a llocat ive efficiency s tudy, World Bank, Washington, DC, http://hdl.handle.net/10986/21104
,2014, HIV resource needs, availabilities and gaps across ASEAN countries (Presented to the ASEAN Health Ministers Meeting), Hanoi, Vietnam, http://optimamodel.com/pubs/ASEAN,%205%20Sept%202014.pdf
,2014, Niger's HIV Response: Targeted Investments for a Healthy Future, The World Bank, Washington DC, http://hdl.handle.net/10986/20600
,2014, Optimizing allocation of resources for HIV/AIDS responses: presented to the United Nations General Assembly, https://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf
,2013, AIDS Funding Landscape in Asia and the Pacific, 2013-2023: Towards ending AIDS in Asia and the Pacific through investments, innovation, country-ownership and shared responsibility, The Kirby Institute, University of New South Wales, Sydney Australia
,2013, Return on investment of needle-syringe programs in the Philippines., The Kirby Institute, UNSW, Sydney Australia, http://optimamodel.com/pubs/philippines-report.pdf
,2012, Assessment of the allocation of HIV funding in Indonesia. (Prepared for the Global HIV/AIDS Program of the World Bank), The Kirby Institute, University of New South Wales and School of Public Health, University of Indonesia
,2012, Determine cost-effective and efficient allocation of HIV resources for the Republic of Armenia. (Prepared for the Global HIV/AIDS Program of the World Bank.), The Kirby Institute, University of New South Wales, and HART Consultancy, Kuala Lumpur, Sydney / Malaysia
,2012, Getting to Zero: HIV prevention resource needs and optimal allocations in Armenia. (Prepared for The Global Fund to Fight AIDS, Tuberculosis and Malaria.), The Kirby Institute, University of New South Wales
,2011, Evaluation of the epidemiological impact of harm reduction programs on HIV in Vietnam, The National Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney Australia
,2011, HIV in Indonesia: Data Triangulation Report. MSM, waria, FSW, male clients of FSW, and IDU. (Prepared for the Global HIV/AIDS Program of the World Bank.), The Kirby Institute, The University of New South Wales, Sydney
,2011, NSW HIV Modelling & Acceptability Project: Effectiveness and acceptability of HIV interventions in NSW., National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney Australia
,2011, The Papua New Guinea HIV Model: Explaining the past, describing the present, and forecasting the future of the HIV Epidemic in PNG Volume 1-3, The Kirby Institute, The University of New South Wales, Sydney, Australia
,2009, Evaluation of the potential impact of the global economic crisis on HIV epidemics in Southeast Asia (prepared for AusAID), National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
,2009, Final Technical Report – Phase A of the National Gay Men’s Syphilis Action Plan: Modelling evidence and research on acceptability of interventions for controlling syphilis in Australia., National Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney, https://kirby.unsw.edu.au/sites/default/files/hiv/attachment/SyphilisPhaseAReport.pdf
,Preprints
2024, Evaluating the impact of COVID-19 on the HIV epidemic among men who have sex with men in Australia: A modelling study, http://dx.doi.org/10.1101/2024.12.15.24318054
,